Latest Supply Agreements News

Clover Corporation Limited reported a standout FY25 with robust revenue growth and a sharp rise in profitability, underpinned by strategic market expansion and product innovation. The company’s strengthened balance sheet and optimistic FY26 outlook signal continued momentum.

BlueScope confirms its first-half FY2026 earnings guidance at the lower end of expectations, highlighting a mix of regional challenges and growth initiatives as it navigates cost pressures and market shifts.

Radiopharm Theranostics has secured ethics approval to begin a Phase 1 clinical trial of RAD 402, a pioneering radiotherapeutic targeting advanced prostate cancer using terbium-161. This marks a significant step in developing a potentially safer, more effective treatment option.

Coronado Global Resources posted a $109.5 million net loss for Q3 2025 amid subdued metallurgical coal markets and announced a proposed refinancing deal with Stanwell Corporation to strengthen its financial position.

Condor Energy has signed a non-binding MoU with Promigas Perú to jointly explore natural gas supply and distribution opportunities from the Piedra Redonda gas field, aiming to unlock value in northern Peru’s energy market.

First Graphene has completed its initial industrial-scale shipment of graphene-enhanced TPU masterbatch to PT Alasmas, marking a key milestone in commercialising advanced materials for durable work boots in Southeast Asia.

FBR Limited has inked a non-binding Memorandum of Understanding with Fraser Lyne Constructions for the sale of a Hadrian® bricklaying robot unit valued at A$7.8 million, aiming to tackle New South Wales' housing shortage with advanced automation.

Mandrake Resources has signed a non-binding Letter of Intent to supply lithium chloride to US refinery Stardust Power, marking a strategic step in the US push for domestic critical minerals.

RooLife Group (ASX, RLG) reported a strategic pivot in Q1 FY2026, landing major supply contracts worth $174 million and raising $2 million to fuel its own-brand product expansion.

European Lithium Limited reports robust quarterly progress highlighted by significant share sales raising over A$187 million and exceptional rare earth drilling results at its Greenland Tanbreez Project.

Northern Minerals reports a robust Definitive Feasibility Study and secures conditional funding interest, positioning Browns Range as a critical supplier of heavy rare earths by 2028.

Clarity Pharmaceuticals has bolstered its financial position with a $203 million institutional placement and reported positive Phase II trial results for its lead prostate cancer diagnostic, Cu-SAR-bisPSMA. The company also expanded its pipeline with promising preclinical data on a pan-cancer agent and secured a key copper-67 supply agreement to support future commercialisation.